The association between side effects and adherence to antidepressants among primary care community-dwelling older adults

Reference

• Bray, G. M., & Huggett, D. L. (2016). Neurological diseases, disorders and injuries in Canada: Highlights of a National Study. Canadian Journal of Neurological Sciences/Journal Canadien Des Sciences Neurologiques, 43(1), 5–14.
   Google Scholar
• Bull, S. A., Hunkeler, E. M., Lee, J. Y., Rowland, C. R., Williamson, T. E., Schwab, J. R., & Hurt, S. W. (2002). Discontinuing or switching selective serotonin-reuptake inhibitors. The Annals of Pharmacotherapy, 36(4), 578–584.
   PubMed Web of Science ®Google Scholar
• Burra, T. A., Chen, E., McIntyre, R. S., Grace, S. L., Blackmore, E. R., & Stewart, D. E. (2007). Predictors of self-reported antidepressant adherence. Behavioral Medicine (Washington, D.C.), 32(4), 127–134.
   PubMed Web of Science ®Google Scholar
• Canadian Coalition For Seniors’ Mental Health. (2006). National guidelines for senior’s mental health: The assessment and treatment of depression. Retrieved from https://ccsmh.ca/wp-content/uploads/2016/03/NatlGuideline_Depression.pdf
   Google Scholar
• Canadian Institute for Health Information. (2018). Drug use among seniors in Canada, 2016. Retrieved from https://secure.cihi.ca/free_products/drug-use-among-seniors-2016-en-web.pdf
   Google Scholar
• Charlesworth, C. J., Smit, E., Lee, D. S., Alramadhan, F., & Odden, M. C. (2015). Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 70(8), 989–995.
   PubMed Web of Science ®Google Scholar
• de Boer, B. J., Bots, M. L., Nijeholt, A. A., Moors, J. P., & Verheij, T. J. (2005). The prevalence of bother, acceptance, and need for help in men with erectile dysfunction. The Journal of Sexual Medicine, 2(3), 445–450.
   PubMed Web of Science ®Google Scholar
• De las Cuevas, C., Penate, W., & Sanz, E. J. (2014). Risk factors for non-adherence to antidepressant treatment in patients with mood disorders. European Journal of Clinical Pharmacology, 70(1), 89–98.
   PubMed Web of Science ®Google Scholar
• Demyttenaere, K. (2009). Factors underlying antidepressant nonadherence: Questions and answers. Primary Psychiatry, 16(9), e0179290.
   Google Scholar
• Derouesne, C., Poitreneau, J., & Hugonot, L. (1999). [Mini-Mental State Examination: A useful method for the evaluation of the cognitive status of patients by the clinician. Consensual French version]. La Presse médicale, 28(21), 1141–1148.
   PubMed Web of Science ®Google Scholar
• Fawzi, W., Abdel Mohsen, M. Y., Hashem, A. H., Moussa, S., Coker, E., & Wilson, K. C. M. (2012). Beliefs about medications predict adherence to antidepressants in older adults. International Psychogeriatrics, 24(01), 159–169.
   PubMedGoogle Scholar
• Food and Drug Administration. (2017). Learning about Side Effects. Retrieved from https://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm196029.htm
   Google Scholar
• Giron, M. S., Fastbom, J., & Winblad, B. (2005). Clinical trials of potential antidepressants: To what extent are the elderly represented: A review. International Journal of Geriatric Psychiatry, 20(3), 201–217.
   PubMed Web of Science ®Google Scholar
• Glassman, A. H. (1998). Cardiovascular effects of antidepressant drugs: Updated. International Clinical Psychopharmacology, 13(Suppl 5), S25–S30.
   PubMedGoogle Scholar
• Goethe, J. W., Woolley, S. B., Cardoni, A. A., Woznicki, B. A., & Piez, D. A. (2007). Selective serotonin reuptake inhibitor discontinuation: Side effects and other factors that influence medication adherence. Journal of Clinical Psychopharmacology, 27(5), 451–458.
   PubMed Web of Science ®Google Scholar
• Gregoire, J. P., Guibert, R., Archambault, A., & Contandriopoulos, A. P. (1992). Medication Compliance in a Family Practice: Testing a self-report questionnaire in a primary care setting. Canadian Family Physician, 38, 2333–2337.
   PubMed Web of Science ®Google Scholar
• Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004). Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: Patient report versus physician estimate. The Journal of Clinical Psychiatry, 65(7), 959–965.
   PubMed Web of Science ®Google Scholar
• Katz, A. J., Dusetzina, S. B., & Farley, J. F. (2012). Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: Influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 32(3), 234–243.
   Google Scholar
• Kelly, K., Posternak, M., & Alpert, J. E. (2008). Toward achieving optimal response: Understanding and managing antidepressant side effects. Dialogues in Clinical Neuroscience, 10(4), 409–418.
   PubMedGoogle Scholar
• Khawam, E. A., Laurencic, G., & Malone, D. A. Jr.(2006). Side effects of antidepressants: An overview. Cleveland Clinic Journal of Medicine, 73(4), 351–353. 356–361.
   PubMed Web of Science ®Google Scholar
• Kostev, K., Ehlken, B., Rex, J., Engelhard, J., Altmann, V., & Heilmaier, C. (2014). Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment? Value Health, 17(7), A460.
   PubMed Web of Science ®Google Scholar
• Lin, E. H., Von Korff, M., Katon, W., Bush, T., Simon, G. E., Walker, E., & Robinson, P. (1995). The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care, 33(1), 67–74.
   PubMed Web of Science ®Google Scholar
• Lorenz, D., Schwieger, D., Moises, H., & Deuschl, G. (2006). Quality of life and personality in essential tremor patients. Movement Disorders: Official Journal of the Movement Disorder Society, 21(8), 1114–1118.
   PubMed Web of Science ®Google Scholar
• MacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J. V., … Ravindran, A. V. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. The Canadian Journal of Psychiatry, 61(9), 588–603.
   PubMed Web of Science ®Google Scholar
• Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57–65.
   PubMed Web of Science ®Google Scholar
• Maidment, R., Livingston, G., & Katona, C. (2002). Just keep taking the tablets: Adherence to antidepressant treatment in older people in primary care. International Journal of Geriatric Psychiatry, 17(8), 752–757.
   PubMed Web of Science ®Google Scholar
• Mark, T. L., Joish, V. N., Hay, J. W., Sheehan, D. V., Johnston, S. S., & Cao, Z. (2011). Antidepressant use in geriatric populations: The burden of side effects and interactions and their impact on adherence and costs. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 19(3), 211–221.
   PubMed Web of Science ®Google Scholar
• Milan, R. (2018). [The association between side effects and adherence to antidepressants among older adults]. Retrieved from http://hdl.handle.net/11143/13352
   Google Scholar
• Morgan, S. G., Daw, J. R., & Law, M. R. (2013). Rethinking Pharmacare in Canada. C.D. Howe Institute. Retrieved from https://www.cdhowe.org/sites/default/files/attachments/research_papers/mixed/Commentary_384_0.pdf
   Google Scholar
• Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
   PubMed Web of Science ®Google Scholar
• Morkem, R., Barber, D., Williamson, T., & Patten, S. B. (2015). A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012. The Canadian Journal of Psychiatry, 60(12), 564–570.
   PubMed Web of Science ®Google Scholar
• Preville, M., Lamoureux-Lamarche, C., & Vasiliadis, H. M. (2014). The 6-month prevalence of posttraumatic stress syndrome (PTSS) among older adults: Validity and reliability of the PTSS scale. The Canadian Journal of Psychiatry, 59(10), 548–555.
   PubMed Web of Science ®Google Scholar
• Rice, A. M. (2011). Successful affiliations: Principles and practices. Frontiers of Health Services Management, 27(4), 13–18. discussion 39–41.
   PubMedGoogle Scholar
• Robotham, D. (2011). Sleep and mental health. Ment Health Today, p. 21–23.
   Google Scholar
• Smitherman, T. A., Burch, R., Sheikh, H., & Loder, E. (2013). The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache, 53(3), 427–436.
   PubMed Web of Science ®Google Scholar
• Uddin, M. A., Soivong, P., Lasuka, D., & Juntasopeepun, P. (2017). Factors related to quality of life among older adults in Bangladesh: A cross sectional survey. Nursing & Health Sciences, 19(4), 518–524.
   PubMed Web of Science ®Google Scholar
• Uddin, M. S., Al Mamun, A., Asaduzzaman, M., Hosn, F., Abu Sufian, M., Takeda, S., … Sujan, M. A. R. (2018). Spectrum of disease and prescription pattern for outpatients with neurological disorders: An Empirical Pilot Study in Bangladesh. Annals of Neurosciences, 25(1), 25–37.
   PubMed Web of Science ®Google Scholar
• Vasiliadis, H. M., Chudzinski, V., Gontijo-Guerra, S., & Preville, M. (2015). Screening instruments for a population of older adults: The 10-item Kessler Psychological Distress Scale (K10) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). Psychiatry Res, 228(1), 89–94.
   PubMed Web of Science ®Google Scholar
• Wong, J., Motulsky, A., Eguale, T., Buckeridge, D. L., Abrahamowicz, M., & Tamblyn, R. (2016). Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA, 315(20), 2230–2232.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Retrieved from http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
   Google Scholar